期刊
NEUROSCIENCE
卷 159, 期 1, 页码 16-20出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2008.12.026
关键词
dyskinesia; in vivo microdialysis; L-DOPA; noradrenaline; intrastriatal; Parkinson's disease
L-DOPA-induced dyskinesia is known as involuntary debilitating movement, which limits quality of life in patients suffering from Parkinson's disease. The present study focuses on the role of the neurotransmitter noradrenaline (NA) on dyskinetic movements in comparison to the effect of L-DOPA. Rats were unilaterally lesioned with 6-hydroxydopamine and treated with L-DOPA/benserazide (6/15 mg/kg, p.o.) to induce stable dyskinetic movements. On the day of the experiment, NA (0.04 nmol/min, 0.4 nmol/min) and L-DOPA (0.04 nmol/min, 0.4 nmol/min) were perfused into the lesioned and non-lesioned striatum of dyskinetic rats using the reverse in vivo microdialysis technique. Neither NA nor L-DOPA treatment of the non-lesioned striatum produced any dyskinetic behavior. In contrast, administration Of L-DOPA 0.4 nmol/min into the lesioned striatum led to a significant increase in dyskinesia indicated by abnormal axial, limb and orolingual movements. Notably, perfusion with NA 0.4 nmol/min into the lesioned striatum revealed a highly significant induction of dyskinetic movements, which are similar to the dyskinesia subtype profile Of L-DOPA. In conclusion, NA is as potent as L-DOPA to express dyskinetic movements in L-DOPA-primed rats. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据